As HCL systems become embedded within routine diabetes care, responsibility for service delivery rests with NHS Boards, which are expected to provide access in line with relevant NICE and SIGN guidance, based on clinical need and individual patient circumstances.The Scottish Government will continue to work with NHS Boards and national partners to consider how data on diabetes technologies can best be collected and reported, including whether additional information could support greater transparency, service planning and the identification of unwarranted variation in access across Scotland.